The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-Bromo-N-[2-[3-(3,4-dichlorophenyl)ureido]phenyl]benzenesulfonamide ID: ALA4456441
PubChem CID: 89717800
Max Phase: Preclinical
Molecular Formula: C19H14BrCl2N3O3S
Molecular Weight: 515.22
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc(Cl)c(Cl)c1)Nc1ccccc1NS(=O)(=O)c1ccc(Br)cc1
Standard InChI: InChI=1S/C19H14BrCl2N3O3S/c20-12-5-8-14(9-6-12)29(27,28)25-18-4-2-1-3-17(18)24-19(26)23-13-7-10-15(21)16(22)11-13/h1-11,25H,(H2,23,24,26)
Standard InChI Key: MLGWNWBDRNPYGS-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
40.7688 -5.3530 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.3643 -4.6473 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
39.9553 -5.3504 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.6556 -4.2447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0710 -4.2394 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.7803 -4.6453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6538 -3.4306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9460 -3.0282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2421 -3.4407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2505 -4.2599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9589 -4.6586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5310 -3.0381 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
41.7803 -5.4614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4887 -5.8673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1958 -5.4559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1901 -4.6345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4811 -4.2324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.4744 -3.4152 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.1787 -3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8897 -3.4035 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.1719 -2.1836 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.5941 -2.9891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.3041 -3.3937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.0080 -2.9800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.0017 -2.1620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.2856 -1.7594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.5847 -2.1755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.2760 -0.9423 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
46.7054 -1.7466 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 2 1 0
2 5 1 0
5 6 1 0
4 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 4 1 0
9 12 1 0
6 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 6 1 0
17 18 1 0
18 19 1 0
19 20 1 0
19 21 2 0
20 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 22 1 0
26 28 1 0
25 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 515.22Molecular Weight (Monoisotopic): 512.9316AlogP: 6.20#Rotatable Bonds: 5Polar Surface Area: 87.30Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 7.27CX Basic pKa: ┄CX LogP: 6.23CX LogD: 5.92Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.38Np Likeness Score: -1.99
References 1. (2014) Serine racemase inhibitor,